IPSCs: Induced Back to Controversy

Overview

Journal Cell Stem Cell

Publisher Cell Press

Specialty Cell Biology

Date 2011 Apr 9

PMID 21474093

Citations 30

Authors

Athanasia D Panopoulos

Sergio Ruiz

Juan Carlos Izpisua Belmonte

Affiliations

Soon will be listed here.

Abstract

Several recent reports (Mayshar et al., 2010; Laurent et al., 2011; Lister et al., 2011; Gore et al., 2011; Hussein et al., 2011) uncover genetic and epigenetic alterations in induced pluripotent stem cells, stimulating debate about their future. However, will these important findings really impact what we hope to gain?

Citing Articles

The Journey of iPSC-derived OPCs in Demyelinating Disorders: From Generation to Transplantation.

Lohrasbi F, Ghasemi-Kasman M, Soghli N, Ghazvini S, Vaziri Z, Abdi S Curr Neuropharmacol. 2023; 21(9):1980-1991.

PMID: 36825702 PMC: 10514531. DOI: 10.2174/1570159X21666230220150010.

Retinal Pigment Epithelium Transplantation: Past, Present, and Future.

Khan A, Utheim T, Eidet J J Ophthalmic Vis Res. 2023; 17(4):574-580.

PMID: 36620704 PMC: 9806312. DOI: 10.18502/jovr.v17i4.12325.

The Application of Induced Pluripotent Stem Cells Against Liver Diseases: An Update and a Review.

Zhang L, Pu K, Liu X, Bae S, Nguyen R, Bai S Front Med (Lausanne). 2021; 8:644594.

PMID: 34277651 PMC: 8280311. DOI: 10.3389/fmed.2021.644594.

Application of stem cell-derived retinal pigmented epithelium in retinal degenerative diseases: present and future.

Luo M, Chen Y Int J Ophthalmol. 2018; 11(1):150-159.

PMID: 29376004 PMC: 5767671. DOI: 10.18240/ijo.2018.01.23.

Induced Pluripotent Stem Cells: Advances in the Quest for Genetic Stability during Reprogramming Process.

Turinetto V, Orlando L, Giachino C Int J Mol Sci. 2017; 18(9).

PMID: 28902128 PMC: 5618601. DOI: 10.3390/ijms18091952.